A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment
Clinical trial NCT05241834 · COMPLETED
Trial details
- NCT number
- NCT05241834
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-23
- Primary completion
- 2024-09-17
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.